Jin Medical International (ZJYL) Invested Capital (2022 - 2025)

Jin Medical International has disclosed Invested Capital across 4 years of filings, most recently posting $21.8 million for Q3 2025.

• Invested Capital for Q3 2025 came in at $21.8 million, down 23.66% year-over-year; the trailing twelve-month figure through Sep 2025 was $21.8 million (down 23.66% YoY), and the FY2025 annual result was $21.8 million, down 23.66% from the prior year.
• Invested Capital came in at $21.8 million for Q3 2025 at Jin Medical International, down from $27.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $28.6 million in Q3 2024 to a low of $15.2 million in Q3 2022.
• The 4-year median for Invested Capital is $25.1 million (2023), against an average of $23.9 million.
• Across the five-year window, Invested Capital surged 57.39% in 2023 and fell 23.66% in 2025, its largest moves.
• Jin Medical International's Invested Capital stood at $15.2 million in 2022, then jumped by 57.39% to $24.0 million in 2023, then rose by 19.07% to $28.6 million in 2024, then declined by 23.66% to $21.8 million in 2025.
• The last three Invested Capital figures came in at $21.8 million (Q3 2025), $27.8 million (Q1 2025), and $28.6 million (Q3 2024), per Business Quant data.